FLEXI-PORT™ Power Injectable Implantable Port
Port & Catheter, Implanted, Subcutaneous, Intravascular. 510(k) K260916, from Portal Access, Inc. (Miami Beach, FL). Product code LJT, class 2.
As of Nov 20, 2026, K260916 is an FDA 510(k) held by Portal Access, Inc., substantially equivalent on Jun 17, 2026 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
The FLEXI-PORT Power Injectable Implantable Port is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications including anti-cancer medications (chemotherapy), I.V. fluids, parenteral nutrition solutions, blood products, and for withdrawal of blood samples.
- PowerPort™ ClearVUE™ Slim Implantable Ports and PowerPort™ ClearVUE™ Slim Implantable PortsK242328 · Bard Access Systems, Inc. · Oct 31, 2024
- Vaccess™ CT Low-Profile Power-Injectable Implantable Port; Vaccess™ CT Power-Injectable Implantable Port; PowerPort™…K252478 · Bard Access Systems, Inc. · Sep 5, 2025
- PowerPort™ isp Implantable Port; PowerPort™ Slim Implantable Port; PowerPort™ M.R.I. ™ Implantable Port; PowerPort™…K251253 · Bard Access Systems, Inc. · Jun 18, 2025
- PowerPort™ ClearVUE™ Slim Implantable Ports and PowerPort™ ClearVUE™ Slim Implantable PortsK242328 · Bard Access Systems, Inc. · Oct 31, 2024
- PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port; PowerPort™ ClearVUE™ isp ECG Enabled Implantable Port;…K232737 · Bard Peripheral Vascular, Inc. · Dec 8, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 19, 2026
- Review panel
- General Hospital
- Regulation
- 21 CFR 880.5965
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files